Small molecule inhibitors enhancing tumor immunogenicity by modulating antigen processing
Developed small molecule inhibitors of ERAP1 to reprogram antigen processing in cancer cells, enhancing their immunogenicity. This approach potentially complements immunotherapies like CAR T-cells by broadening antigenic...